Second funding round
Monday 5 July 2010 - News EyeTechCare
EyeTechCare raises EUR 7.5 million in a second funding round and speeds up its development.
These funds will enable the company to complete the clinical trial of EyeOP1, a novel, ultrasound-based medical device for the treatment of glaucoma.
EyeTechCare SA, which is developing non-invasive therapeutic medical devices using ultrasound technology, announces the completion of a EUR 7.5-million funding round. The funds were provided by Lyon-based insurance company SHAM, a first time investor, and Crédit Agricole Private Equity (CAPE), one of EyeTechCare’s existing shareholders.
> Read the Press Release